AccessPak for HIV PEP Expanded with Kaletra and Bremelanotide Acetate
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Bremelanotide Acetate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: bremelanotide
Brand name: Vyleesi
Synonyms: Bremelanotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Brentuximab Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Brentuximab vedotin
- AccessPak for HIV PEP Expanded with Kaletra-Breo Ellipta
- AccessPak for HIV PEP Expanded with Kaletra-Brethine
- AccessPak for HIV PEP Expanded with Kaletra-Brethine Subcutaneous
- AccessPak for HIV PEP Expanded with Kaletra-Bretylium
- Bremelanotide Acetate-AccessPak for HIV PEP Expanded with Viracept
- Bremelanotide Acetate-Accolate
- Bremelanotide Acetate-Accretropin
- Bremelanotide Acetate-Accucaine
- Bremelanotide Acetate-AccuHist Drops
- Bremelanotide Acetate-AccuHist PDX Drops